Study to Understand Risk Information to Support and Empower
Launched by UNIVERSITY OF CALIFORNIA, DAVIS · Feb 28, 2023
Trial Information
Current as of June 26, 2025
Enrolling by invitation
Keywords
ClinConnect Summary
No description provided
Gender
FEMALE
Eligibility criteria
- Inclusion Criteria:
- • Current pregnancy complicated by gestational diabetes mellitus (GDM)
- • Age: 18 years and older
- • Contact with the Kaiser Permanente Northern California (KPNC) Regional Perinatal Service Center
- • Able to communicate in English
- Exclusion Criteria:
- • Diagnosis of diabetes before pregnancy
- • Maternal or infant current hospitalization
- • Pregnancy loss
- • History of eating disorder
- • Previously requested not to receive research invitations
About University Of California, Davis
The University of California, Davis (UC Davis) is a leading research institution renowned for its commitment to advancing healthcare through innovative clinical trials and studies. With a strong focus on interdisciplinary collaboration, UC Davis leverages its extensive expertise in medical research, education, and patient care to drive breakthroughs in various fields, including medicine, public health, and agriculture. The university's clinical trial programs emphasize rigorous scientific methodology and ethical standards, aiming to translate research findings into impactful treatments and improved patient outcomes. Through its state-of-the-art facilities and a dedicated team of researchers and healthcare professionals, UC Davis is at the forefront of transforming healthcare practices and addressing critical health challenges.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Oakland, California, United States
Pleasanton, California, United States
Patients applied
Trial Officials
Susan D Brown, PhD
Principal Investigator
University of California, Davis
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials